News
MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...
Novartis expanded a commercial collaboration with Shanghai Pharma. Plus more. 1. China investigating former head of food and drug watchdog (Reuters) Bi Jingjuan, the former head of the China FDA ...
AstraZeneca agrees to $51 million settlement in Seroquel antitrust class action Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the ...
The Company reported advancing its efforts to strengthen the protection of its intellectual property across additional Asian markets, following the recently granted patent in India for a ...
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
BetterLife Pharma Inc. + Watchlist Alert BETRF US Closed Last Updated: May 23, 2025 9:55 a.m. EDT Delayed quote $ 0.0810-0.0033-3.91% Previous Close $0.0843 Toggle Chart Options Advanced Charting ...
Six so-called patient advocacy groups are working to advance corporate profits in the pharmaceutical industry by routinely lobbying in line with Big Pharma’s priorities and opposing drug price ...
Hosted on MSN23d
India's Mankind Pharma beats profit estimates on demand for drugs to treat chronic illnesses(Reuters) -Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results